- Ọgwụgwọ
- Ihe akaebe
- Neuroblastoma
- Ọrịa siri ike
- Ihe akaebe
- TILS
- Ọgwụgwọ NK Cell
- Myasthenia Gravis (MG)
- Ọrịa kansa ọbara Lymphoblastic dị oke njọ (B-ALL)
- Ọrịa Lupus Erythematosus Sistemụ (SLE)
- Ọrịa kansa ọbara Lymphoblastic dị oke njọ (T-ALL)
- Ọrịa Lymphoma na-abụghị Hodgkin (NHL)
- Ọtụtụ Myeloma (MM)
- Lymphom B-cell buru ibu nke gbasaara agbasa
- Ọrịa kansa ọbara B-lymphocytic
- Myeloma
Ọrịa kansa ọbara Lymphoblastic dị oke njọ (T-ALL)-10
Otu nwa nwoke dị afọ iri na atọ aha ya bụ Yangyang si Panzhihua, Sichuan Province, mere CAR-T wee jiri akwanye ya n'ime akpa ahụ.
Na mbụ, Yangyang pụtara "ọnyá gbasasịrị n'ahụ ya niile, ya na ike ọgwụgwụ" na Eprel 12, 2021. A chọpụtara na ọ nwere ọrịa leukemia lymphoblastic (ụdị T-cell) nke nwere ọbara ọgbụgba n'ime ụbụrụ na ọrịa akpa ume nke a chọpụtara site na nyocha MICM nke ụmị ọkpụkpụ n'ụlọ ọgwụ buru ibu na Chongqing. O mere usoro ọgwụgwọ chemotherapy ugboro atọ n'ụlọ ọgwụ ọzọ, mana ụmị ọkpụkpụ azaghị. Ka ọ na-erule mmalite ọnwa Juun, ọ malitere inwe adịghị ike n'akụkụ abụọ nke ahụ ya ma ghara ịga ije.
Na Julaị 1, 2021, a nabatara Yangyang na Ngalaba Hematology Ward nke 2 anyị. O debanyere aha na nnwale ahụike CD7 CAR-T na Julaị 8 ma natara ọgwụ mkpụrụ ndụ CD7 CAR-T onwe ya na Julaị 26 maka ọgwụgwọ immunotherapy. Ụbọchị iri na isii ka e tinyere ọgwụ ahụ, ọdịdị ọkpụkpụ gosiri na ọ gbapụrụ, ebe cytometry flow gosiri na ọ nwere 0.07% nke T lymphoblasts na-adịghị ike. Mgbe e nyere ya ọgwụgwọ anụ ahụ, ọ laghachiri n'ike ije n'onwe ya. Ka ọ na-erule ụbọchị 31 mgbe e tinyere ya ọgwụ ahụ, ọkpụkpụ ya gbapụrụ kpamkpam.
Ugbu a, a kpọfere Yangyang na Ngalaba nke Isii nke Ngalaba Mgbanwe Ọkpụkpụ maka ọgwụgwọ ọzọ. Dr. Hai si Ngalaba nke Isii kwuru na Yangyang anọwo na-arụkọ ọrụ ma na-enwe olileanya n'oge ọgwụgwọ ya. O mere mgbanwe mkpụrụ ndụ hematopoietic (site n'aka nna ya) na Septemba 28. A nabatara ọnọdụ ndị ọrụ ibe Ngalaba Hematology mepụtara maka mgbanwe eriri ya nke ọma.
Ndị ọrịa a, tupu ha abanye na nnwale ahụike CD7 CAR-T, gosipụtara ọtụtụ ihe mgbaàmà dịka nlọghachi azụ mgbe a mịnyechara ha ihe, ngosipụta abụọ nke T/myeloid, ọrịa leukemia T-cell acute refractory/resisted, ọrịa leukemia sistemụ akwara etiti, ọbara ọgbụgba n'ime ụbụrụ, na ọrịa akpa ume. Mgbe a nyochachara ma gwọọ ya site na ọgwụgwọ CD7 CAR-T, ha niile nwetara mgbaghara zuru oke, na-emezu ihe a tụrụ anya ya.
Ebe anyị na-ahụ maka ọgwụgwọ CAR-T emeela nnyocha nke ọma n'ihe gbasara ọgwụgwọ CAR-T ma nweta ahụmịhe bara ụba n'ịchịkwa CRS. Maka ọtụtụ ndị sonyere, ihe kacha njọ bụ oke ahụ ọkụ. "Enwere m ike iwepụ ya kpamkpam, yabụ ahụ ọkụ abụghị ihe ọ bụla! Achọrọ m ka ọtụtụ mmadụ mara na BIOOCUS nwere ike ime CAR-T!" ka Yangyang si Fujian kwuru mgbe a tọhapụrụ ya.
nkọwa2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

